Abbott Laboratories
A pharmaceuticals health care company.
Based in DC
🤖
AI Overview
With $1.5M in lobbying spend across 30 quarterly filings, Abbott Laboratories is a significant lobbying presence.
$1.5M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
1
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $150K |
| 2025 | $150K |
Lobbying Firms
W STRATEGIES, LLC
What They Lobby For
- FY 2018 Continuing resolution as it relates to suspension of the medical device tax. H.R.4617: Protect Medical Innovation Act.
- H.R.1892: Bipartisan Budget Act of 2018. H.R.1625: Consolidated Appropriations Act, 2018.
- Medicare conditions of participation as it relates to antibiotics. Education about the regulation of continuous glucose monitor technologies.
- Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act. Education about the importance of non-pharmacological pain treatment options, including medical devices. H.R.195, as it relates to the HEALTHY KIDS Act CHIP reauthorization.
- H.R.4617: Protect Medical Innovation Act.
- Education about the importance of proper reimbursement for home monitoring services for anticoagulation management. Education about the regulation of continuous glucose monitor technologies including CMS regulation of CGM.
- Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act. Reauthorization of PAHPA (Pandemic All Hazards Preparedness Act). H.R.6: Support for Patients and Communities Act as it relates to provisions designed to promote the importance of non-pharmacological pain treatment options, including medical devices.
- Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act. H.R.6378/S.2852: Reauthorization of PAHPA (Pandemic All-Hazards Preparedness Act). H.R.6: Support for Patients and Communities Act as it relates to provisions designed to promote the importance of non-pharmacological pain treatment options, including medical devices.
- Education around VA coverage of CGM devices.
- Education about the implementation of PAMA with respect to physician office labs.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.